Hikma Pharmaceuticals Plc Director/PDMR Shareholding (6675Q)
22 Giugno 2020 - 12:24PM
UK Regulatory
TIDMHIK
RNS Number : 6675Q
Hikma Pharmaceuticals Plc
22 June 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Release of a pledge Darhold Limited over 3,500,000
transaction Ordinary Shares of 10 pence each in Hikma Pharmaceuticals
PLC in favour of Citibank N.A. Darhold Limited
is defined as a Person Closely Associated with
the Executive Chairman, who is a director and
shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 3,500,000
d) Aggregated information Aggregated volume: 3,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Release of a pledge Darhold Limited over 3,500,000
transaction Ordinary Shares of 10 pence each in Hikma Pharmaceuticals
PLC in favour of Citibank N.A. Darhold Limited
is defined as a Person Closely Associated with
the Executive Vice Chairman, who is a director
and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 3,500,000
d) Aggregated information Aggregated volume: 3,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mohammed 'Ali' Al-Husry
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Release of a pledge Darhold Limited over 3,500,000
transaction Ordinary Shares of 10 pence each in Hikma Pharmaceuticals
PLC in favour of Citibank N.A. Darhold Limited
is defined as a Person Closely Associated with
the Non-Executive Director, who is a director
and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 3,500,000
d) Aggregated information Aggregated volume: 3,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBGGDLDDDDGGD
(END) Dow Jones Newswires
June 22, 2020 06:24 ET (10:24 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024